{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:34:32Z","timestamp":1781292872688,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical University of Gdansk"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The acceptability and palatability of a dosage form are extremely important to improve patient compliance. Mixing oral solid dosage forms with food carriers is often necessary to ease swallowing and provide the taste-masking effect. The present research investigated how a liquid or semisolid carrier influences the disintegration time and drug dissolution rate of pellets and minitablets with diazepam. The disintegration of pellets and minitablets in liquid carriers (water, milk and apple juice) was determined using a texture analyser. Dissolution tests were performed for the dosage forms dispersed in gel vehicles (2% carmellose and 0.5% carbomer gels) or applesauce. The disintegration of minitablets in water and apple juice was fast (1\u00a0min), but it slowed to 3 and 5\u00a0min in milk and gel vehicles, respectively. The pellets disintegrated in liquid carriers within 3\u00a0min. The drug dissolution rate in 0.1\u00a0M HCl depended on the gel viscosity in this medium. The preserved high viscosity of a carmellose gel inhibited the dissolution of diazepam. On the other hand, the viscosity of the carbomer gel decreased rapidly, and in effect, the dissolution rate of diazepam from the incorporated pellets or minitablets was comparable to the dissolution from loose pellets or minitablets.<\/jats:p>","DOI":"10.1208\/s12249-020-01761-6","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T17:03:02Z","timestamp":1596214982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of Different Liquid and Semisolid Vehicles Selected for Oral Administration of Pellets and Minitablets with Diazepam: In Vitro Investigation"],"prefix":"10.1208","volume":"21","author":[{"given":"Hanna","family":"Kotlowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Szymanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Sznitowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"issue":"16","key":"1761_CR1","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s40265-014-0297-2","volume":"74","author":"F Liu","year":"2014","unstructured":"Liu F, Ranmal S, Batchelor HK, Orlu-Gul M, Ernest TB, Thomas IW, et al. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs. 2014;74(16):1871\u201389.","journal-title":"Drugs."},{"issue":"1\u20132","key":"1761_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ijpharm.2015.06.047","volume":"491","author":"DA van Riet-Nales","year":"2015","unstructured":"van Riet-Nales DA, Ferreira JA, Schobben AFAM, de Neef BJ, Egberts TCG, Rademaker CMA. Methods of administering oral formulations and child acceptability. Int J Pharm. 2015;491(1\u20132):261\u20137.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1761_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ijpharm.2017.02.029","volume":"521","author":"N Drumond","year":"2017","unstructured":"Drumond N, van Riet-Nales DA, Karapinar-\u00c7arkit F, Stegemann S. Patients\u2019 appropriateness, acceptability, usability and preferences for pharmaceutical preparations: results from a literature review on clinical evidence. Int J Pharm. 2017;521(1\u20132):294\u2013305.","journal-title":"Int J Pharm"},{"key":"1761_CR4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S0022-3476(05)82496-5","volume":"120","author":"JC Cloyd","year":"1992","unstructured":"Cloyd JC, Kriel RL, Jones-Saete CM, Ong BY, Jancik JT, Remmel RP. Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference. J Pediatr. 1992;120:634\u20138.","journal-title":"J Pediatr"},{"issue":"2","key":"1761_CR5","first-page":"108","volume":"81","author":"S Zlotkin","year":"2003","unstructured":"Zlotkin S, Antwi KY, Schauer C, Yeung G. Use of microencapsulated iron(II) fumarate sprinkles to prevent recurrence of anaemia in infants and young children at high risk. Bull World Health Organ. 2003;81(2):108\u201315.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"1761_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/QAI.0000000000000135","volume":"66","author":"V Musiime","year":"2014","unstructured":"Musiime V, Fillekes Q, Kekitiinwa A, Kendall L, Keishanyu R, Namuddu R, et al. The pharmacokinetics and acceptability of lopinavir\/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children. J Acquir Immune Defic Syndr. 2014;66(2):148\u201354.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"1761_CR7","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.xphs.2018.11.013","volume":"108","author":"RG Strickley","year":"2019","unstructured":"Strickley RG. Pediatric oral formulations: an updated review of commercially available pediatric oral formulations since 2007. J Pharm Sci. 2019;108(4):1335\u201365.","journal-title":"J Pharm Sci"},{"key":"1761_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ajps.2019.05.003","volume":"15","author":"HS Lee","year":"2019","unstructured":"Lee HS, Lee JJ, Kim MG, Kim KT, Cho CW, Kim DD, et al. Sprinkle formulations\u2014a review of commercially available products. Asian J Pharm Sci. 2019;15:292\u2013310. https:\/\/doi.org\/10.1016\/j.ajps.2019.05.003.","journal-title":"Asian J Pharm Sci"},{"issue":"3200","key":"1761_CR9","first-page":"1","volume":"20","author":"M Trofimiuk","year":"2019","unstructured":"Trofimiuk M, Wasilewska K, Winnicka K. How to modify drug release in paediatric dosage forms? Novel technologies and modern approaches with regard to children\u2019s population. Int J Mol Sci. 2019;20(3200):1\u201322.","journal-title":"Int J Mol Sci"},{"key":"1761_CR10","unstructured":"FDA. US Department of Health and Human Services. Guidance for industry: size of beads in drug products labeled for sprinkle. 2012."},{"key":"1761_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-4899-8011-3_11","volume-title":"Pediatric formulations: a roadmap","author":"SR Ranmal","year":"2014","unstructured":"Ranmal SR, Barker SA, Tuleu C. Paediatric solid formulations. In: Bar-Shalom D, Rose K, editors. Pediatric formulations: a roadmap. New York: Springer; 2014. p. 153\u201370."},{"issue":"1\u20132","key":"1761_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.02.068","volume":"485","author":"A Kluk","year":"2015","unstructured":"Kluk A, Sznitowska M, Brandt A, Sznurkowska K, Plata-Nazar K, Mysliwiec M, et al. Can preschool-aged children swallow several minitablets at a time? Results from a clinical pilot study. Int J Pharm. 2015;485(1\u20132):1\u20136.","journal-title":"Int J Pharm"},{"key":"1761_CR13","unstructured":"FDA. US Department of Health and Human Services. Guidance for industry: use of liquids and\/or soft foods as vehicles for drug administration: general considerations for selection and in vitro methods for product quality assessment. 2018."},{"issue":"2","key":"1761_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1208\/s12249-016-0671-3","volume":"18","author":"F Karkossa","year":"2017","unstructured":"Karkossa F, Krueger A, Urbaniak J, Klein S. Simulating different dosing scenarios for a child-appropriate valproate ER formulation in a new pediatric two-stage dissolution model. AAPS PharmSciTech. 2017;18(2):309\u201316.","journal-title":"AAPS PharmSciTech"},{"key":"1761_CR15","unstructured":"FDA. U.S. Department of Health and Human Services. Guidance for industry: food-effect bioavailability and fed bioequivalence studies. 2002."},{"issue":"3","key":"1761_CR16","first-page":"122","volume":"71","author":"E Kersten","year":"2016","unstructured":"Kersten E, Barry A, Klein S. Physicochemical characterisation of fluids and soft foods frequently mixed with oral drug formulations prior to administration to children. Pharmazie. 2016;71(3):122\u20137.","journal-title":"Pharmazie."},{"key":"1761_CR17","first-page":"28","volume":"1","author":"S Jackson","year":"2017","unstructured":"Jackson S, Naunton M. Optimising medicine administration in patients with swallowing difficulties. Australian Pharm. 2017;1:28\u201331.","journal-title":"Australian Pharm"},{"issue":"1\u20132","key":"1761_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijpharm.2013.10.052","volume":"460","author":"A Kluk","year":"2014","unstructured":"Kluk A, Sznitowska M. Application properties of oral gels as media for administration of minitablets and pellets to paediatric patients. Int J Pharm. 2014;460(1\u20132):228\u201333.","journal-title":"Int J Pharm"},{"issue":"1","key":"1761_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpharm.2008.07.030","volume":"364","author":"P Kaur","year":"2008","unstructured":"Kaur P, Kim K. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits. Int J Pharm. 2008;364(1):27\u201335.","journal-title":"Int J Pharm"},{"issue":"2","key":"1761_CR20","first-page":"127","volume":"38","author":"S Wilson","year":"2016","unstructured":"Wilson S, Houpt M. Project usap 2010: use of sedative agents in pediatric dentistry-a 25-year follow-up survey. Pediatr Dent. 2016;38(2):127\u201333.","journal-title":"Pediatr Dent"},{"key":"1761_CR21","unstructured":"Roxane Laboratories Inc. Diazepam Intensol Oral Solution \u2013 The Summary of Product Characteristics. 2012.https:\/\/docs.boehringer-ingelheim.com\/Prescribing%20Information\/PIs\/Roxane\/Diazepam\/Diazepam%20Oral%20Solution.pdf. Accessed: 16 April 2020."},{"issue":"1\u20132","key":"1761_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijpharm.2004.08.019","volume":"292","author":"G Abdelbary","year":"2005","unstructured":"Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, Piccerelle P. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm. 2005;292(1\u20132):29\u201341.","journal-title":"Int J Pharm"},{"issue":"1","key":"1761_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/03639045.2018.1526184","volume":"45","author":"A Grube","year":"2019","unstructured":"Grube A, Gerlitzki C, Brendel M. Dissolution or disintegration \u2013 substitution of dissolution by disintegration testing for a fixed dose combination product. Drug Dev Ind Pharm. 2019;45(1):130\u20138.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1\u20132","key":"1761_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijpharm.2018.08.021","volume":"551","author":"FL Lopez","year":"2018","unstructured":"Lopez FL, Ernest TB, Orlu M, Tuleu C. The effect of administration media on palatability and ease of swallowing of multiparticulate formulations. Int J Pharm. 2018;551(1\u20132):67\u201375.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1761_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijpharm.2004.06.012","volume":"282","author":"G Bonacucina","year":"2004","unstructured":"Bonacucina G, Martelli S, Palmieri GF. Rheological, mucoadhesive and release properties of Carbopol gels in hydrophilic cosolvents. Int J Pharm. 2004;282(1\u20132):115\u201330.","journal-title":"Int J Pharm"},{"key":"1761_CR26","unstructured":"EMA. Committee for Medicinal Products for Human Use. Guideline on pharmaceutical development of medicines for paediatric use. Vol. 44. 2013."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01761-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-020-01761-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01761-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T23:12:30Z","timestamp":1627686750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-020-01761-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1761"],"URL":"https:\/\/doi.org\/10.1208\/s12249-020-01761-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"9 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"213"}}